NO960207D0 - Oftalmisk lösning basert på diklofenak og tobramycin samt anvendelse av denne - Google Patents

Oftalmisk lösning basert på diklofenak og tobramycin samt anvendelse av denne

Info

Publication number: NO960207D0
Authority: NO; Norway
Prior art keywords: diclofenac; tobramycin; solution based; ophthalmic solution; tobramicine
Prior art date: 1994-05-17

Application number

NO960207A

Other languages

English (en)

Other versions

NO960207L (no

NO308645B1 (no

Inventor

Antonio Lopez Cabrera

Gemma Torrella Cabello

Jose Alberto Vallet Mas

Michael Van Wie Bergamini

Original Assignee

Cusi Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-17

Filing date

1996-01-17

Publication date

1996-01-17

1996-01-17 Application filed by Cusi Lab filed Critical Cusi Lab

1996-01-17 Publication of NO960207D0 publication Critical patent/NO960207D0/no

1996-03-15 Publication of NO960207L publication Critical patent/NO960207L/no

2000-10-09 Publication of NO308645B1 publication Critical patent/NO308645B1/no

Links

DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title abstract 2
229960001259 diclofenac Drugs 0.000 title abstract 2
229940054534 ophthalmic solution Drugs 0.000 title 1
239000002997 ophthalmic solution Substances 0.000 title 1
NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 title 1
229960000707 tobramycin Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 2
206010061218 Inflammation Diseases 0.000 abstract 1
239000002738 chelating agent Substances 0.000 abstract 1
239000000017 hydrogel Substances 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO960207A 1994-05-17 1996-01-17 Oftalmisk løsning basert pÕ diclofenac og tobramycin samt anvendelse av denne NO308645B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES09401078A ES2079320B1 (es)	1994-05-17	1994-05-17	Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
PCT/ES1994/000084 WO1995031179A1 (es)	1994-05-17	1994-09-07	Disolucion oftalmica a base de diclofenaco y tobramicina y sus aplicaciones

Publications (3)

Publication Number	Publication Date
NO960207D0 true NO960207D0 (no)	1996-01-17
NO960207L NO960207L (no)	1996-03-15
NO308645B1 NO308645B1 (no)	2000-10-09

Family

ID=8286285

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO960207A NO308645B1 (no)	1994-05-17	1996-01-17	Oftalmisk løsning basert pÕ diclofenac og tobramycin samt anvendelse av denne

Country Status (20)

Country	Link
US (1)	US5597560A (no)
EP (1)	EP0711546B1 (no)
KR (1)	KR100353377B1 (no)
CN (1)	CN1098678C (no)
AT (1)	ATE198417T1 (no)
AU (1)	AU696853B2 (no)
BG (1)	BG100289A (no)
BR (1)	BR9407330A (no)
CA (1)	CA2167383C (no)
DE (1)	DE69426529T2 (no)
DK (1)	DK0711546T3 (no)
ES (1)	ES2079320B1 (no)
FI (1)	FI116884B (no)
GR (1)	GR3035633T3 (no)
HU (1)	HUT74164A (no)
NO (1)	NO308645B1 (no)
OA (1)	OA10570A (no)
PL (1)	PL312615A1 (no)
PT (1)	PT711546E (no)
WO (1)	WO1995031179A1 (no)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19729879C2 (de) *	1997-07-11	1999-07-08	Mann Gerhard Chem Pharm Fab	Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
US6395746B1 (en)	1998-09-30	2002-05-28	Alcon Manufacturing, Ltd.	Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) *	1998-09-30	2004-04-06	Alcon, Inc.	Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en)	1998-09-30	2003-01-21	Alcon Manufacturing, Ltd.	Compositions and methods for treating otic, ophthalmic and nasal infections
US7056893B2 (en)	1999-03-31	2006-06-06	Insite Vision, Inc.	Topical treatment for prevention of ocular infections
US6239113B1 (en)	1999-03-31	2001-05-29	Insite Vision, Incorporated	Topical treatment or prevention of ocular infections
US8173164B2 (en) *	1999-06-17	2012-05-08	Gruenenthal Gmbh	Oral administration forms for administering a fixed tramadol and diclofenac combination
US20020061281A1 (en) *	1999-07-06	2002-05-23	Osbakken Robert S.	Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
BR0012674A (pt)	1999-07-22	2002-09-17	Aventis Pharma Inc	Formulações farmacêuticas preservadas
US8512718B2 (en)	2000-07-03	2013-08-20	Foamix Ltd.	Pharmaceutical composition for topical application
BR0212898A (pt) *	2001-09-21	2004-10-13	Alcon Inc	Método de tratamento de infecções do ouvido médio
US7928147B2 (en) *	2002-04-11	2011-04-19	Teva Animal Health, Inc.	Antimicrobial wash and carrier solutions, and uses thereof
WO2004006957A1 (en) *	2002-07-15	2004-01-22	Alcon, Inc.	Pharmaceutical compositions for otic use
IL152486A0 (en) *	2002-10-25	2003-05-29	Meir Eini	Alcohol-free cosmetic and pharmaceutical foam carrier
US20050069566A1 (en) *	2003-08-04	2005-03-31	Foamix Ltd.	Foam carrier containing amphiphilic copolymeric gelling agent
US8486376B2 (en) *	2002-10-25	2013-07-16	Foamix Ltd.	Moisturizing foam containing lanolin
US7820145B2 (en)	2003-08-04	2010-10-26	Foamix Ltd.	Oleaginous pharmaceutical and cosmetic foam
US20050271596A1 (en) *	2002-10-25	2005-12-08	Foamix Ltd.	Vasoactive kit and composition and uses thereof
US10117812B2 (en) *	2002-10-25	2018-11-06	Foamix Pharmaceuticals Ltd.	Foamable composition combining a polar solvent and a hydrophobic carrier
US20060018937A1 (en) *	2002-10-25	2006-01-26	Foamix Ltd.	Steroid kit and foamable composition and uses thereof
US20050205086A1 (en) *	2002-10-25	2005-09-22	Foamix Ltd.	Retinoid immunomodulating kit and composition and uses thereof
US20070292359A1 (en) *	2002-10-25	2007-12-20	Foamix Ltd.	Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en)	2002-10-25	2017-06-06	Foamix Pharmaceuticals Ltd.	Nonsteroidal immunomodulating kit and composition and uses thereof
ES2532906T5 (es) *	2002-10-25	2022-03-23	Foamix Pharmaceuticals Ltd	Espuma cosmética y farmacéutica
US20070292461A1 (en) *	2003-08-04	2007-12-20	Foamix Ltd.	Oleaginous pharmaceutical and cosmetic foam
US7700076B2 (en) *	2002-10-25	2010-04-20	Foamix, Ltd.	Penetrating pharmaceutical foam
US20060193789A1 (en) *	2002-10-25	2006-08-31	Foamix Ltd.	Film forming foamable composition
US20070292355A1 (en) *	2002-10-25	2007-12-20	Foamix Ltd.	Anti-infection augmentation foamable compositions and kit and uses thereof
US20080206161A1 (en) *	2002-10-25	2008-08-28	Dov Tamarkin	Quiescent foamable compositions, steroids, kits and uses thereof
US20050186142A1 (en) *	2002-10-25	2005-08-25	Foamix Ltd.	Kit and composition of imidazole with enhanced bioavailability
US9211259B2 (en) *	2002-11-29	2015-12-15	Foamix Pharmaceuticals Ltd.	Antibiotic kit and composition and uses thereof
US7704518B2 (en) *	2003-08-04	2010-04-27	Foamix, Ltd.	Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en)	2002-10-25	2008-06-12	Foamix Ltd.	Foam prepared from nanoemulsions and uses
US9265725B2 (en) *	2002-10-25	2016-02-23	Foamix Pharmaceuticals Ltd.	Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en)	2002-10-25	2014-12-02	Foamix Pharmaceuticals Ltd.	Foamable composition and uses thereof
AU2003303191A1 (en) *	2002-12-20	2004-07-14	Deepak Bahri	Composition comprising diclofenac for treating otic pain and inflammation
US8129431B2 (en)	2003-01-21	2012-03-06	Senju Pharmaceutical Co., Ltd.	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
US7575739B2 (en)	2003-04-28	2009-08-18	Foamix Ltd.	Foamable iodine composition
EP1481804A1 (en)	2003-05-28	2004-12-01	F.Hoffmann-La Roche Ag	A device for dispensing drops of a liquid
US8486374B2 (en) *	2003-08-04	2013-07-16	Foamix Ltd.	Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20080069779A1 (en) *	2003-08-04	2008-03-20	Foamix Ltd.	Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US8795693B2 (en)	2003-08-04	2014-08-05	Foamix Ltd.	Compositions with modulating agents
CA2536482C (en) *	2003-08-25	2012-07-24	Foamix Ltd.	Penetrating pharmaceutical foam
WO2005027977A2 (en) *	2003-09-22	2005-03-31	Agis Industries (1983) Ltd.	Diclofenac compositions for the treatment of skin disorders
WO2005046700A1 (ja)	2003-11-14	2005-05-26	Senju Pharmaceutical Co., Ltd.	アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤
US8367086B1 (en) *	2004-02-02	2013-02-05	S.S. Steiner, Inc.	Process and product for inhibiting or preventing bacterial infections
ZA200507017B (en) *	2004-02-04	2007-03-28	Foamix Ltd	Cosmetic and pharmaceutical foam with solid matter
US20050214382A1 (en) *	2004-03-29	2005-09-29	Erning Xia	Zinc preservative composition and method of use
JP2005310310A (ja) *	2004-04-23	2005-11-04	Sanyo Electric Co Ltd	トラッキングバランス調整装置
US20060046970A1 (en) *	2004-08-31	2006-03-02	Insite Vision Incorporated	Topical otic compositions and methods of topical treatment of prevention of otic infections
US20060073173A1 (en) *	2004-10-04	2006-04-06	Maria Banach	Large-scale manufacturing process for the production of pharmaceutical compositions
US8067402B2 (en)	2005-12-12	2011-11-29	Allaccem, Inc.	Methods and systems for coating an oral surface
CN1981869B (zh) *	2005-12-14	2011-04-06	信谊药厂	含普拉洛芬的复方非载体抗菌眼用制剂及其制备方法
ATE549022T1 (de) *	2006-08-07	2012-03-15	Bausch & Lomb	Behandlung von infektionen und deren folgeleiden mit kombinierten dissoziierten glocucorticoid- rezeptor-agonisten und antiinfektionswirkstoffen
CN101563058A (zh) *	2006-09-08	2009-10-21	弗米克斯有限公司	有色的或可着色的能起泡的组合物和泡沫
US20080260655A1 (en)	2006-11-14	2008-10-23	Dov Tamarkin	Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
EP2073794A2 (en) *	2006-11-14	2009-07-01	Foamix Ltd.	Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
WO2008085913A1 (en) *	2007-01-04	2008-07-17	Rib-X Pharmaceuticals, Inc.	Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections
US20080292560A1 (en) *	2007-01-12	2008-11-27	Dov Tamarkin	Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
EP2125026B1 (en)	2007-02-21	2014-09-24	AllAccem, Inc.	Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
PL1986473T3 (pl) *	2007-04-03	2017-07-31	Tsinghua University	Organiczne urządzenie elektroluminescencyjne
US8636982B2 (en)	2007-08-07	2014-01-28	Foamix Ltd.	Wax foamable vehicle and pharmaceutical compositions thereof
US8153618B2 (en) *	2007-08-10	2012-04-10	Allaccem, Inc.	Bridged polycyclic compound based compositions for topical applications for pets
US8188068B2 (en) *	2007-08-10	2012-05-29	Allaccem, Inc.	Bridged polycyclic compound based compositions for coating oral surfaces in pets
US8153617B2 (en) *	2007-08-10	2012-04-10	Allaccem, Inc.	Bridged polycyclic compound based compositions for coating oral surfaces in humans
US20090074833A1 (en) *	2007-08-17	2009-03-19	Whiteford Jeffery A	Bridged polycyclic compound based compositions for controlling bone resorption
US20090130029A1 (en) *	2007-11-21	2009-05-21	Foamix Ltd.	Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en)	2007-11-30	2016-09-13	Foamix Pharmaceuticals Ltd.	Foam containing benzoyl peroxide
WO2009090495A2 (en)	2007-12-07	2009-07-23	Foamix Ltd.	Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en)	2007-12-07	2013-08-27	Foamix Ltd.	Oil-based foamable carriers and formulations
EP2242476A2 (en) *	2008-01-14	2010-10-27	Foamix Ltd.	Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20100004218A1 (en) *	2008-06-20	2010-01-07	Whiteford Jeffery A	Bridged polycyclic compound based compositions for renal therapy
US20100016270A1 (en) *	2008-06-20	2010-01-21	Whiteford Jeffery A	Bridged polycyclic compound based compositions for controlling cholesterol levels
WO2010125470A2 (en)	2009-04-28	2010-11-04	Foamix Ltd.	Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en)	2009-07-29	2017-04-11	Foamix Ltd.	Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
EP2482788B1 (en)	2009-10-02	2022-12-14	Journey Medical Corporation	Topical tetracycline compositions
US9849142B2 (en)	2009-10-02	2017-12-26	Foamix Pharmaceuticals Ltd.	Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011057131A1 (en)	2009-11-09	2011-05-12	Spotlight Technology Partners Llc	Polysaccharide based hydrogels
CA2780274C (en)	2009-11-09	2018-06-26	Spotlight Technology Partners Llc	Fragmented hydrogels
CN102526738B (zh) *	2010-12-27	2016-03-30	沈阳兴齐眼药股份有限公司	一种复方眼用制剂、其制备方法和用途
CA2978573A1 (en)	2016-09-08	2018-03-08	Foamix Pharmaceuticals Ltd.	Compositions and methods for treating rosacea and acne
CN107865966A (zh) *	2016-09-23	2018-04-03	刘力	局部给药的复方氨基糖苷类药物组合物
KR102283681B1 (ko) *	2020-01-17	2021-07-29	조선대학교 산학협력단	렌즈 형상의 약물 전달 시스템 및 이의 제조 방법
EP4192247A4 (en) *	2020-08-04	2025-01-08	Harrow IP, LLC	Antibacterial compositions and methods for fabricating thereof
EP4112041A1 (en) *	2021-06-30	2023-01-04	GSK Consumer Healthcare SARL	Micellar solution comprising diclofenac
CN116270447B (zh) *	2023-02-21	2025-11-11	江苏广承药业有限公司	一种妥布霉素滴眼液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4087538A (en) *	1976-09-09	1978-05-02	Merck & Co., Inc.	Ophthalmic suspensions
US4407792A (en) *	1979-05-09	1983-10-04	Alcon Laboratories, Inc.	Sustained release ophthalmic drug dosage
NZ196700A (en) *	1980-04-18	1983-04-12	Smith & Nephew Ass	Anti-inflammatory compositions containing 5-benzoyl-1-methylpyrrole-2-acetic acid derivatives
US4478822A (en) *	1983-05-16	1984-10-23	Merck & Co., Inc.	Drug delivery system utilizing thermosetting gels
US4668506A (en) *	1985-08-16	1987-05-26	Bausch & Lomb Incorporated	Sustained-release formulation containing and amino acid polymer
DE3612537C1 (de) *	1986-04-14	1987-07-16	Dispersa Ag	Arzneimittel zur Behandlung von Entzuendungen im Auge
US5414011A (en) *	1987-09-11	1995-05-09	Syntex (U.S.A.) Inc.	Preservative system for ophthalmic formulations
AU626798B2 (en) *	1987-09-11	1992-08-13	Syntex (U.S.A.) Llc	Preservative system for ophthalmic formulations
AU606515B2 (en) *	1988-03-09	1991-02-07	Alcon Laboratories, Inc.	Combination of tobramycin and steroids for topical ophthalmic use
ES2079994B1 (es) *	1992-10-07	1996-08-01	Cusi Lab	Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.

1994
- 1994-05-17 ES ES09401078A patent/ES2079320B1/es not_active Expired - Fee Related
- 1994-09-07 WO PCT/ES1994/000084 patent/WO1995031179A1/es not_active Ceased
- 1994-09-07 HU HU9600095A patent/HUT74164A/hu unknown
- 1994-09-07 DE DE69426529T patent/DE69426529T2/de not_active Expired - Fee Related
- 1994-09-07 PT PT94926248T patent/PT711546E/pt unknown
- 1994-09-07 KR KR1019960700285A patent/KR100353377B1/ko not_active Expired - Fee Related
- 1994-09-07 BR BR9407330A patent/BR9407330A/pt not_active Application Discontinuation
- 1994-09-07 AU AU76160/94A patent/AU696853B2/en not_active Ceased
- 1994-09-07 CA CA002167383A patent/CA2167383C/en not_active Expired - Fee Related
- 1994-09-07 CN CN94193294A patent/CN1098678C/zh not_active Expired - Fee Related
- 1994-09-07 DK DK94926248T patent/DK0711546T3/da active
- 1994-09-07 AT AT94926248T patent/ATE198417T1/de not_active IP Right Cessation
- 1994-09-07 PL PL94312615A patent/PL312615A1/xx unknown
- 1994-09-07 EP EP94926248A patent/EP0711546B1/en not_active Expired - Lifetime
1995
- 1995-04-10 US US08/419,387 patent/US5597560A/en not_active Expired - Lifetime
1996
- 1996-01-17 OA OA60766A patent/OA10570A/en unknown
- 1996-01-17 BG BG100289A patent/BG100289A/xx unknown
- 1996-01-17 FI FI960232A patent/FI116884B/fi active IP Right Grant
- 1996-01-17 NO NO960207A patent/NO308645B1/no not_active IP Right Cessation
2001
- 2001-03-23 GR GR20010400478T patent/GR3035633T3/el unknown

Also Published As

Publication number	Publication date
KR960703581A (ko)	1996-08-31
FI960232L (fi)	1996-03-15
US5597560A (en)	1997-01-28
ES2079320A1 (es)	1996-01-01
PT711546E (pt)	2001-06-29
HK1017806A1 (en)	1999-11-26
BG100289A (bg)	1996-12-31
CA2167383C (en)	2001-11-20
AU696853B2 (en)	1998-09-17
AU7616094A (en)	1995-12-05
BR9407330A (pt)	1996-06-18
ES2079320B1 (es)	1996-10-16
DE69426529T2 (de)	2001-08-09
CN1130351A (zh)	1996-09-04
NO960207L (no)	1996-03-15
KR100353377B1 (ko)	2002-12-26
EP0711546A1 (en)	1996-05-15
DK0711546T3 (da)	2001-04-23
GR3035633T3 (en)	2001-06-29
ATE198417T1 (de)	2001-01-15
WO1995031179A1 (es)	1995-11-23
FI116884B (fi)	2006-03-31
FI960232A0 (fi)	1996-01-17
EP0711546B1 (en)	2001-01-03
DE69426529D1 (de)	2001-02-08
CA2167383A1 (en)	1995-11-23
PL312615A1 (en)	1996-04-29
NO308645B1 (no)	2000-10-09
OA10570A (en)	2002-06-20
CN1098678C (zh)	2003-01-15
HUT74164A (en)	1996-11-28

Legal Events

Date	Code	Title	Description
2010-04-26	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO960207L (no)	1996-03-15	Oftalmisk lösning basert på diklofenak og tobramycin samt anvendelse av denne
ITMI920074A1 (it)	1993-07-16	Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
IT1277707B1 (it)	1997-11-11	Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
PT723538E (pt)	2002-05-31	Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
NL300389I1 (nl)	2009-07-01	Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
ES2091068T3 (es)	1996-10-16	Combinaciones de productos activos fungicidas.
ATE209897T1 (de)	2001-12-15	Lagerstabile ophthalmische zusammensetzungen, umfassend diclofenac und ofloxacin
GR3027685T3 (en)	1998-11-30	Ophthalmic compositions and methods for preserving and using same
FI913094L (fi)	1992-02-11	POLYSACKARIDDERIVATOR. SIIRRETTY PAEIVAEMAEAERAE-FOERSKJUTET DATUM PL 14 ç 09.08.91.
DE69526369D1 (de)	2002-05-16	Entzündungshemmende augentropfen
ID27276A (id)	2001-03-22	Oksazolidinon-oksazolidinon untuk merawat infeksi-infeksi mata
NO951989L (no)	1995-05-19	Anvendelse av amidoaminer i öyepreparater
CO4290351A1 (es)	1996-04-17	Proceso
ES2078175B1 (es)	1996-10-16	Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
ATE117208T1 (de)	1995-02-15	Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
ES2079127T3 (es)	1996-01-01	Composicion herbicida.
AU6975591A (en)	1991-07-18	Pharmaceutical composition for treating or preventing retroviral infections
WO1996025183A3 (en)	1996-10-10	Ophthalmic compositions including peptides and peptide derivatives and methods for using same
ES2099736T3 (es)	1997-06-01	Utilizacion de derivados de la 15-deshidroxi-16-oxoprostaglandina en el tratamiento de las alergias.
MX9704035A (es)	1998-02-28	1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
RU95105076A (ru)	1996-12-20	Способ пластики конъюнктивы
ATE90565T1 (de)	1993-07-15	Behandlung des schocks mit cyclodextrin und dessen derivaten.
HN1993199340A (es)	1999-04-23	N-(4,6 dime) amin - 3 - tri - 2 - sulfo o una de sus sales utiles composicion herbecida que contine el mismo y proceso para la produccion del compuestos.
RU1819738C (ru)	1993-06-07	Способ изготовлени колеса
IT220068Z2 (it)	1993-06-09	"dispositivo di chiusura per l'allacciatura di una calzatura"